Scrutiny Of Patient Assistance Program Funding Is Rising
Law360 (December 5, 2019, 3:45 PM EST) -- Pharmaceutical manufacturers donate hundreds of millions of dollars a year to charitable funds that help patients afford the cost of their prescriptions. Known as independent charity patient assistance programs, or PAPs, these funds enable patients to have access to critical drugs and medications.
While the Office of Inspector General of the U.S. Department of Health and Human Services has not disapproved of this relationship between drug companies and independent charities as long as the charity maintains the required hallmarks of independence, the past few years have seen an increase in the scrutiny of PAPs and their donors.
In November, Florida-based The...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!